Palliative care for caregivers should be initiated earlier rather than later
the ONA take:
A team of investigators, affiliated with University of Alabama at Birmingham, School of Nursing/Department of Medicine, examined the impact of early versus delayed intervention with regard to family caregivers for those with cancer.
For a period of slightly over 2 years, the researchers selected caregivers of patients with advanced cancer to receive intervention either soon after enrollment of 3 months afterward. Caregivers were recruited from a National Cancer Institute (NCI) cancer center, a Veterans Administration Medical Center, and two community outreach clinics. Intervention consisted of the following: three telephone coaching sessions per week, a monthly follow-up, and a bereavement call. One hundred twenty two caregivers participated in the study process.
Measured factors for caregivers in the two groups were depression, quality of life, and burden (objective, stress, and demand).
Data showed a lower rate of depression (both at the three-month mark and in terminal decline analysis) for the caregivers in the early group. The early intervention group also demonstrated lower stress burden, though quality of life was rated similar for both groups.
Study results were presented at the 50th Annual Meeting of the American Society of Clinical Oncology, in Chicago, Illinois.
The impact of early versus delayed intervention with regard to family caregivers for those with cancer.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|